Calpain is activated in degenerating photoreceptors in the rd1 mouse

Francois Paquet-Durand1, Seifollah Azadi, Stefanie M Hauck

  • 1Ophthalmology Department, University of Lund, Lund, Sweden. francois.paquet-durand@med.lu.se

Journal of Neurochemistry
|January 13, 2006
PubMed

Insights

Increased calpain activity correlates with photoreceptor cell death in the rd1 mouse model of retinitis pigmentosa. Calpain inhibitors may offer a therapeutic strategy for inherited retinal degeneration.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Molecular Biology

Background:

  • Inherited retinal degeneration, such as retinitis pigmentosa, causes blindness.
  • Calpain activation is implicated in cell death, but its role in retinal degeneration is unclear.

Purpose of the Study:

  • Investigate calpain expression, activity, and role in the rd1 mouse model of inherited retinal degeneration.
  • Determine if calpain activation correlates with photoreceptor cell death.

Main Methods:

  • Microarray analysis of gene transcription (CREB-1, calpastatin, calpain genes).
  • Immunofluorescence and immunoblotting for calpain and calpastatin protein expression.
  • Enzymatic assay to measure calpain activity in photoreceptors.

Main Results:

  • Reduced CREB-1 and calpastatin expression in rd1 retinas.
  • Substantially increased calpain activity in rd1 photoreceptors, peaking at postnatal day 13.
  • Calpain activity coincided with photoreceptor cell death.
  • Calpain inhibitors reduced in situ calpain activity.

Conclusions:

  • Calpain activation is strongly correlated with photoreceptor cell death in the rd1 mouse.
  • Calpain inhibitors show potential for preventing or delaying photoreceptor degeneration in inherited retinal diseases.